News and Trends 17 Dec 2018
Series B Boosts British Biotech’s Cell Therapy Automation With €22.6M
The UK company Synthace has raised €22.6M to develop its software platform to automate and improve the manufacturing process in gene and cell therapy. The round, led by Hong Kong-based investor Horizons Ventures, will help to fund the development of Synthace’s software designed to automate key protocols in the lab. Furthermore, the funding will help […]